These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 241376)

  • 1. Enzymatic activity of the second component of complement.
    Cooper NR
    Biochemistry; 1975 Sep; 14(19):4245-51. PubMed ID: 241376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cleavage of C2 by C1s into the antigenically distinct fragments C2a and C2b: demonstration of binding of C2b to C4b.
    Nagasawa S; Stroud RM
    Proc Natl Acad Sci U S A; 1977 Jul; 74(7):2998-3001. PubMed ID: 70787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement C2 receptor inhibitor trispanning and the beta-chain of C4 share a binding site for complement C2.
    Inal JM; Schifferli JA
    J Immunol; 2002 May; 168(10):5213-21. PubMed ID: 11994478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional analysis of activated C1s, a subcomponent of the first component of human complement, by monoclonal antibodies.
    Matsumoto M; Nagaki K
    J Immunol; 1986 Nov; 137(9):2907-12. PubMed ID: 2428878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of histamine on monocyte complement production. II. Modulation of protein secretion, degradation and synthesis.
    Lappin D; Moseley HL; Whaley K
    Clin Exp Immunol; 1980 Dec; 42(3):515-22. PubMed ID: 7011615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The purification and properties of the second component of guinea-pig complement.
    Kerr MA; Gagnon J
    Biochem J; 1982 Jul; 205(1):59-67. PubMed ID: 6922702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C3 metabolism in a patient with deficiency of the second component of complement (C2) and discoid lupus erythematosus.
    Wild JH; Zvaifler NJ; Müller-Eberhard HJ; Wilson CB
    Clin Exp Immunol; 1976 May; 24(2):238-48. PubMed ID: 1084239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.
    Halili MA; Ruiz-Gómez G; Le GT; Abbenante G; Fairlie DP
    Biochemistry; 2009 Sep; 48(35):8466-72. PubMed ID: 19642650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cleavage of the second component of complement by plasma proteases: implications in hereditary C1-inhibitor deficiency.
    Smith MA; Kerr MA
    Immunology; 1985 Nov; 56(3):561-70. PubMed ID: 2934317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The properdin pathway: mechanisms of complement activation and analogies to the classical pathway.
    Fearon DT; Austen KF; Ruddy S
    Rheumatology; 1975; 6():2-16. PubMed ID: 1105744
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of iodine and thiol-blocking reagents on complement component C2 and on the assembly of the classical-pathway C3 convertase.
    Kerr MA; Parkes C
    Biochem J; 1984 Apr; 219(2):391-9. PubMed ID: 6611150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and activation of the early components of complement.
    Porter RR
    Fed Proc; 1977 Aug; 36(9):2191-6. PubMed ID: 328305
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantitative studies of the secretion of complement component C3 by resident, elicited and activated macrophages. Comparison with C2, C4 and lysosomal enzyme release.
    Zimmer B; Hartung HP; Scharfenberger G; Bitter-Suermann D; Hadding U
    Eur J Immunol; 1982 May; 12(5):426-30. PubMed ID: 7094993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The second component of human complement: detection of two hemolytic forms in plasma by pH variation.
    Schultz DR; Loos M
    Immunobiology; 1988 Mar; 176(4-5):374-93. PubMed ID: 3391636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of the prime subsites of the C1s protease of the classical complement pathway for recognition of substrates.
    O'Brien G; Quinsey NS; Whisstock JC; Pike RN
    Biochemistry; 2003 Dec; 42(50):14939-45. PubMed ID: 14674770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of C1s and C4. A binding phenomenon.
    Taubman SB
    Biochim Biophys Acta; 1975 Jun; 393(2):542-55. PubMed ID: 125105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonimmunologic complement activation in normal human serum induced by radiographic contrast media.
    Kolb WP; Lang JH; Lasser EC
    J Immunol; 1978 Oct; 121(4):1232-8. PubMed ID: 100552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a C4b binding site on the C2b domain of C2.
    Oglesby TJ; Accavitti MA; Volanakis JE
    J Immunol; 1988 Aug; 141(3):926-31. PubMed ID: 3397535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The reaction of iodine and thiol-blocking reagents with human complement components C2 and factor B. Purification and N-terminal amino acid sequence of a peptide from C2a containing a free thiol group.
    Parkes C; Gagnon J; Kerr MA
    Biochem J; 1983 Jul; 213(1):201-9. PubMed ID: 6555044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.